About Katherine “Katie” Rubino

Katherine “Katie” Rubino is a partner in the Corporate department at Wiggin and Dana. Katie frequently represents clients on target discovery collaborations, assisting in structuring spin-offs, divestitures, and out-licensing from pharma, hospital systems, and academic research institutions. She also counsels life sciences companies developing pharmaceuticals, vaccines, antibody products, digital health, medical devices, artificial intelligence, and quantum computing, and advises companies raising growth capital, merger and acquisition transactions, and initial public offerings. Katie is experienced in transactions involving intellectual property rights, strategic partnerships, licensing, and research collaborations. Katie is active in industry organisations and chairs the American Chemical Society’s Chemistry and the Law Division